[1]
S. Oda, Y. Inada, A. Kobayashi, H. Ohta, Production of ethyl (R)-2-hydroxy-4-phenylbutanoate via reduction of ethyl 2-oxo-4-phenylbutanoate in an interface bioreactor, Biosci. Biotechnol .Biochem. 62 (1998) 1762-1767.
DOI: 10.1271/bbb.62.1762
Google Scholar
[2]
P. Sarananan, V.K. Singh, An efficient synthesis of chiral nonracemic diamines:application in asymmetric cynthesis, Tetrabedron Lett. 39 (1998) 167-170.
DOI: 10.1016/s0040-4039(97)10578-0
Google Scholar
[3]
R. Noyori, Asymmetric Catalysis: Science and Opportunities (Nobel Lecture 2001), Adv. Synth. Catal. 345 (2003) 15-32.
DOI: 10.1002/adsc.200390002
Google Scholar
[4]
E.J. Ariëns, Nonchiral, homochiral and composite chiral drugs, Trends Pharmacol. Sci. 14 (1993) 68-75.
DOI: 10.1016/0165-6147(93)90033-g
Google Scholar
[5]
J.M. Palomo, G. Fernandez-Lorente, C. Ortiz, R. Fernandez-Lafuente, J.M. Guisan, Modulation of the enantioselectivity of lipases via controlled immobilization and medium engineering: hydrolytic resolution of mandelic acid esters, Enzyme Microb. Technol. 31 (2002) 775-783.
DOI: 10.1016/s0141-0229(02)00169-2
Google Scholar
[6]
D.Y. Ganapati, P. Sivakumar, Enzyme-catalysed optical resolution of mandelic acid via RS (∓) -methyl mandelate in non-aqueous media, Biochem. Eng. J. 19 (2004) 101-107.
DOI: 10.1016/j.bej.2003.12.004
Google Scholar
[7]
M.D. Lilly, Advances in biotransformation processes, Chem. Eng. Sci. 49 (1994) 151-159.
Google Scholar
[8]
R.N. Patel, Biocatalytic synthesis of intermediates for the synthesis of chiral drug substances, Curr. Opin. Biotechnol. 12 (2001) 587-604.
DOI: 10.1016/s0958-1669(01)00266-x
Google Scholar
[9]
K. Nakamura, Y. Kawai, N. Nakajima, A. Ohno, Stereochemical control of microbial reduction 17: a method for controlling the enantioselectivity of reductions with Bakers'Yeast, Org. Chem. 56 (1991) 4778-4783.
DOI: 10.1021/jo00015a038
Google Scholar